↑Miyazaki T, Kanou Y, Murata Y, Ohmori S, Niwa T, Maeda K, Yamamura H, Seo H (Aug 1996). "Molecular cloning of a novel thyroid hormone-responsive gene, ZAKI-4, in human skin fibroblasts". J Biol Chem. 271 (24): 14567–71. doi:10.1074/jbc.271.24.14567. PMID8662924.
Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery". Genome Res. 6 (9): 791–806. doi:10.1101/gr.6.9.791. PMID8889548.
Rothermel B, Vega RB, Yang J, et al. (2000). "A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling". J. Biol. Chem. 275 (12): 8719–25. doi:10.1074/jbc.275.12.8719. PMID10722714.
Strippoli P, Lenzi L, Petrini M, et al. (2000). "A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2)". Genomics. 64 (3): 252–63. doi:10.1006/geno.2000.6127. PMID10756093.
Fuentes JJ, Genescà L, Kingsbury TJ, et al. (2000). "DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways". Hum. Mol. Genet. 9 (11): 1681–90. doi:10.1093/hmg/9.11.1681. PMID10861295.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.
Qin L, Zhao D, Liu X, et al. (2007). "Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway". Mol. Cancer Res. 4 (11): 811–20. doi:10.1158/1541-7786.MCR-06-0126. PMID17114339.